LAX.SH
VALIANT ORGANICS LIMITED·CHEMICALS 65.05·Chemicals & Petrochemicals Companies
Price
302.7
-2.66%52W Range
Market Cap
₹835.88 Cr
Traded: ₹0.61 Cr (0.07%) 0.0x
Free Float: ₹323.99 Cr (0.19% of FF traded)
Volume · 60D trend
20 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +0.0% | -11.0% | -- | +3.0% | Stable |
| Profit | -- | -24.0% | -30.0% | -- | +881.0% | Stable |
| Return | -- | -29.0% | -15.0% | -19.0% | -- | Stable |
| ROE | -- | +6.0% | +1.0% | -- | -- | Decelerating |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 232 | 218 | 159 | 157 | 204 | 204 | 187 | 160 | 168 | 177 | 141 | 203 | 202 | 271 | 250 | 264 |
| Expenses | 190 | 191 | 146 | 136 | 180 | 183 | 172 | 159 | 152 | 179 | 139 | 188 | 178 | 219 | 212 | 222 |
| Operating Profit | 42 | 26 | 13 | 21 | 25 | 21 | 15 | 1 | 16 | -2 | 3 | 15 | 24 | 52 | 38 | 42 |
| OPM % | 18.0% | 12.0% | 8.0% | 13.0% | 12.0% | 10.0% | 8.0% | 0.5% | 9.0% | -1.2% | 1.8% | 8.0% | 12.0% | 19.0% | 15.3% | 15.9% |
| Other Income | 11 | 5 | 7 | 0 | 2 | 1 | 6 | 3 | 0 | -7 | 0 | 4 | 9 | 3 | 6 | 2 |
| Interest | 5 | 3 | 5 | 4 | 6 | 5 | 6 | 8 | 5 | 7 | 4 | 4 | 4 | 3 | 3 | 3 |
| Depreciation | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 8 | 7 | 7 |
| Profit Before Tax | 37 | 18 | 6 | 7 | 11 | 7 | 6 | -14 | 2 | -25 | -10 | 6 | 20 | 44 | 35 | 34 |
| Tax % | 20.0% | 10.0% | 38.0% | 24.0% | 26.0% | 43.0% | 14.0% | -9.0% | 128.0% | -20.0% | -20.0% | 26.0% | 25.0% | 23.0% | 24.8% | 25.0% |
| Net Profit | 29 | 16 | 4 | 6 | 8 | 4 | 5 | -12 | -1 | -20 | -8 | 5 | 15 | 34 | 26 | 26 |
| Exceptional Items | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | -9 | 0 | 0 | 6 | 0 | 5 | 0 |
| EPS (Rs) | 10.4 | 5.6 | 1.3 | 2.0 | 2.9 | 1.5 | 2.0 | -4.6 | -0.2 | -7.3 | -2.9 | 1.6 | 4.6 | 11.0 | 8.1 | 7.7 |
| Sales Growth (YoY) | 13.3% | 6.8% | -14.8% | -1.8% | 21.7% | 15.3% | 32.2% | -21.1% | -16.8% | -34.9% | -43.5% | -23.1% | -24.1% | -- | -- | -- |
| Sales Growth (QoQ) | -- | 37.1% | 1.3% | -23.0% | 0.0% | 9.1% | 16.9% | -4.8% | -5.1% | 25.5% | -30.5% | 0.5% | -25.5% | 8.2% | -5.2% | -- |
| OP Growth (YoY) | 68.0% | 23.8% | -13.3% | 2000.0% | 56.3% | 1150.0% | 400.0% | -93.3% | -33.3% | -103.8% | -92.1% | -64.2% | -- | -- | -- | -- |
| OP Growth (QoQ) | 61.5% | 100.0% | -38.1% | -16.0% | 19.0% | 40.0% | 1400.0% | -93.8% | 900.0% | -166.7% | -80.0% | -37.5% | -53.8% | 36.2% | -8.8% | -- |
| Profit Growth (YoY) | 254.0% | 274.0% | -98.0% | 144.0% | 1423.0% | 138.0% | 169.0% | -397.0% | -107.0% | -137.0% | -142.0% | -79.0% | -43.0% | -4.0% | -37.0% | -18.0% |
| EPS Growth (YoY) | -- | 274.0% | -34.3% | 143.6% | 1431.8% | 120.5% | 169.2% | -393.0% | -104.8% | -166.8% | -135.3% | -79.5% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | 331.5% | -35.6% | -31.1% | 95.3% | -24.2% | 142.8% | -2004.5% | 97.0% | -155.9% | -281.0% | -65.4% | -58.3% | 35.5% | 4.8% | -- |
| OP Margin | -- | 11.9% | 8.2% | 13.4% | 12.3% | 10.3% | 8.0% | 0.6% | 9.5% | -1.1% | 2.1% | 7.4% | 11.9% | 19.2% | 15.3% | 15.9% |
| Net Margin | -- | 7.3% | 2.5% | 3.8% | 3.9% | 2.0% | 2.7% | -7.5% | -0.6% | -11.3% | -5.7% | 2.5% | 7.4% | 12.6% | 10.4% | 9.7% |
| Material Cost % | 58.0% | 61.0% | 58.0% | 55.0% | 62.0% | 65.0% | 64.0% | 65.0% | 61.0% | 75.0% | 65.0% | 66.0% | 65.0% | 62.0% | 64.0% | 65.0% |
| Employee Cost % | 6.0% | 6.0% | 7.0% | 8.0% | 6.0% | 5.0% | 6.0% | 7.0% | 6.0% | 7.0% | 9.0% | 7.0% | 6.0% | 5.0% | 5.0% | 4.0% |
| P/S | 1.09 | 1.22 | 1.13 | 0.84 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 15.69 | 27.43 | 38.27 | 27.23 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 1.10 | 1.18 | 1.11 | 0.86 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Please find our intimation in captioned subject.
Publication of financial results for the quarter ended June 30, 2026 and Notice to shareholders for the intimation of transfer of unclaimed/unpaid dividend to IEPF.
Please find our intimation in the captioned subject
Please find our intimation in the captioned subject
Change in the Registered Office Address of the Company, subject to approval of the shareholders of the Company in the ensuing AGM.
Intimation of the new corporate office
Re-appointment of a Managing Director, subject to approval of the shareholders of the Company in the ensuing AGM.
Please find our intimation in the captioned subject
Approval of the unaudited financial results for the quarter ended June 30, 2026 and other matters
Valiant Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve financial results for the ....
Please find attached our intimation in the captioned subject
Please find our intimation in the captioned subject
Please find our intimation in the captioned subject
Please find our intimation in captioned subject
Please find our intimation in the captioned subject
Update on Postal Ballot process
Please refer to the attached intimation
Please find our attached intimation on the captioned subject.
Please find the attached Annual Secretarial Compliance Report for the FY 2025-26
Please find attached our intimation on the captaioned subject
Please find our intimation on the captioned subject.
Please find our intimation on the captioned subject.
The Board of Directors of the Company, at its meeting held today i.e. May 19, 2026, has considered and passed the following resolutions: 1) Cessation of the Company as a Partner of Subsidiary; ....
Please find attached the intimation w.r.t. publication of financial results in the newspapers.
Please refer our intimation in the captioned matter
Re-appointment of Internal and Cost Auditors for the FY 2026-27
Valiant Organics Announces Evaluation of Restructuring Options
Please find the attached announcement.
Audited Standalone and Consolidated Financial Results for quarter and year ended March 31, 2026
Valiant Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2026 ,inter alia, to consider and approve the financial results for ....
Newspaper publication regarding Second 100 days Campaign-"Saksham Niveshak"
Please find our intimation in captioned subject
Please find our intimation in captioned subject.
Please find our intimation in captioned subject
Please find our intimation in captioned subject
The Exchange has sought clarification from Valiant Organics Ltd on March 23, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Please find our intimation in captioned subject
Please find our intimation in captioned subject.
Please find our intimation in captioned subject
Please find our intimation in captioned subject
Valiant Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve unaudited financial statements ....
Please find our intimation in captioned subject
Kindly refer to our attached intimation
Please find our intimation in captioned subject
Please find our intimation in captioned subject
Please find our intimation in captioned subject
Please find our intimation in captioned subject.
Please find our intimation in captioned subject
Please find our intimation in captioned subject
Please find our intimation in captioned subject.
Annual Reports
9Credit Ratings
6Concalls
28Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Sep 2025
30 Sept 2025Aug 2025
31 Aug 2025Jul 2025
31 Jul 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Dec 2024
31 Dec 2024Aug 2024
31 Aug 2024Jun 2024
30 Jun 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Sep 2023
30 Sept 2023Aug 2023
31 Aug 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Nov 2022
30 Nov 2022Sep 2022
30 Sept 2022Aug 2022
31 Aug 2022Jul 2022
31 Jul 2022May 2022
31 May 2022Mar 2022
31 Mar 2022Mar 2022
31 Mar 2022Feb 2022
28 Feb 2022Sep 2021
30 Sept 2021